Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany · Hannover · how to bid here →
Your path to submission
- Deadline: 31 December at 00:00 — 114 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- 16% of this buyer's awards went to companies that had already won here before (38 awards since 2017, spread over 32 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 38 awards since 2017
- In this sector the buyer awards roughly every 3 months (26 awards, most recently November 2022) — by that rhythm the next award was due around February 2023. The last award went to Blömeke Druck SRS GmbH.n = 26
- The median procedure drew 4 bids (38 procedures with a bid count); 16% ended with a single bidder. Sector: median 2 bids.n = 38
- From notice to award takes a median 7 days here (9 procedures). Sector: 70 days.n = 9
- Not one of the 38 awards with a known winner country has gone to a foreign company so far. Sector average: 1%.n = 38
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 07/09/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 252 contracts went to foreign companies over the last 3 years (of 21,727 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 34 (from 386 awards).
What the buyer is looking for
Die Kaufmännische Krankenkasse - KKH (im Folgenden KKH) verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmen Rabattverträge nach § 130a Absatz 8 SGB V über den Wirkstoff/ die Wirkstoffe im Rahmen eines sogenannten "Open-House-Verfahrens" abzuschließen. Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss bzw. Beitritt zu einem Rabattvertrag nach § 130a Abs. 8 SGB V zu dem in der Ausschreibung genannten Wirkstoff angeboten. Interessierte pharmazeutische Unternehmen können dazu bei der genannten Kontaktadresse ([email protected]) die Teilnahmeunterlagen sowie den Vertrag anfordern.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in DEU.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Basics GmbH · Leverkusen | 8 | 2013–2016 |
| neuraxpharm Arzneimittel GmbH · Langenfeld | 8 | 2013–2016 |
| betapharm Arzneimittel GmbH · Augsburg | 8 | 2013–2016 |
| mibe GmbH Arzneimittel · Sandersdorf-Brehna | 8 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 8 | 2013–2016 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.